Coronavirus pandemic: daily updated research and data.
Read more

Country-by-country data on COVID-19 vaccinations

This page has a number of charts on vaccination. In the box below you can select any country you are interested in – or several, if you want to compare countries.

All charts on this page will then show data for the countries that you selected.

None selected

How many people have received a coronavirus vaccine?

Tracking COVID-19 vaccination rates is crucial to understand the scale of protection against the virus, and how this is distributed across the global population.

A global, aggregated database on COVID-19 vaccination rates is essential to monitor progress, but it is unfortunately not yet available. When a global, or aggregated regional database — such as European data collated by the European CDC — becomes available, Our World in Data will provide these weekly updates of vaccination rates, presented in our interactive COVID-19 Explorer, and our Complete COVID-19 Dataset.

Until such a database is made available, Our World in Data will be tracking recent announcements on the first countries to administer these vaccinations. Our sources for the data presented here are listed at the bottom of this page.

The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Total number of COVID-19 vaccinations administered

The following map and chart show the total number of COVID-19 vaccination doses administered. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily vaccination rates

The metrics above provide the total number of doses administered — the cumulative doses over time.

The following map and chart show the daily number of COVID-19 vaccination doses administered. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of COVID-19 vaccinations administered per million

The following map and chart show the daily number of COVID-19 vaccination doses administered per million people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Vaccine development: vaccines approved for use and in clinical trials

The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which we’ve known the pathogens for more than a century (like malaria) we still haven’t found an effective vaccine.

The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries. 

The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.

We are on the way to several vaccines against COVID-19 – vaccine trackers monitor the progress:

Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed:

Source information country by country

You can download the full dataset alongside the detailed source descriptions on GitHub.

Note that other countries have also started vaccination campaigns—we’ll add them to our maps and charts as soon as numbers are verifiable based on public official sources.

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

LocationSourceLast observation dateVaccines
ArgentinaGovernment of ArgentinaJanuary 8, 2021Sputnik V
AustriaMinistry of HealthDecember 30, 2020Pfizer/BioNTech
BahrainMinistry of HealthJanuary 8, 2021Sinopharm
BelgiumGovernment vaccination taskforceJanuary 2, 2021Pfizer/BioNTech
BulgariaMinistry of HealthJanuary 9, 2021Pfizer/BioNTech
CanadaCOVID-19 Canada Open Data Working GroupJanuary 8, 2021Moderna, Pfizer/BioNTech
ChileDepartment of Statistics and Health InformationJanuary 6, 2021Pfizer/BioNTech
ChinaNational Health CommissionJanuary 9, 2021CNBG, Sinovac
Costa RicaNational Health CommissionJanuary 8, 2021Pfizer/BioNTech
CroatiaMinistry of HealthJanuary 8, 2021Pfizer/BioNTech
CyprusMinistry of HealthJanuary 6, 2021Pfizer/BioNTech
CzechiaMinistry of HealthJanuary 6, 2021Pfizer/BioNTech
DenmarkStatens Serum InstitutJanuary 8, 2021Pfizer/BioNTech
EnglandGovernment of the United KingdomJanuary 3, 2021Pfizer/BioNTech
EstoniaNational Health BoardJanuary 9, 2021Pfizer/BioNTech
FinlandTHL via Helsingin SanomatJanuary 8, 2021Pfizer/BioNTech
FranceMinistry of HealthJanuary 8, 2021Pfizer/BioNTech
GermanyRobert Koch InstitutJanuary 7, 2021Pfizer/BioNTech
GreeceMinistry of HealthJanuary 8, 2021Pfizer/BioNTech
GuineaNational Health Security AgencyDecember 30, 2020Sputnik V
HungaryGovernment of HungaryJanuary 8, 2021Pfizer/BioNTech
IcelandDirectorate of HealthDecember 30, 2020Pfizer/BioNTech
IrelandHealth Service ExecutiveJanuary 7, 2021Pfizer/BioNTech
IsraelGovernment of IsraelJanuary 7, 2021Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyJanuary 9, 2021Pfizer/BioNTech
KuwaitMinistry of HealthDecember 28, 2020Pfizer/BioNTech
LatviaNational Health ServiceJanuary 8, 2021Pfizer/BioNTech
LithuaniaMinistry of HealthJanuary 8, 2021Pfizer/BioNTech
LuxembourgGovernment of LuxembourgDecember 30, 2020Pfizer/BioNTech
MaltaMinistry of HealthJanuary 3, 2021Pfizer/BioNTech
MexicoSecretary of HealthJanuary 8, 2021Pfizer/BioNTech
NetherlandsNational Institute for Public Health and the EnvironmentJanuary 8, 2021Pfizer/BioNTech
Northern IrelandGovernment of the United KingdomJanuary 3, 2021Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthJanuary 7, 2021Pfizer/BioNTech
OmanMinistry of HealthJanuary 8, 2021Pfizer/BioNTech
PolandMinistry of HealthJanuary 8, 2021Pfizer/BioNTech
PortugalNational Health ServiceJanuary 8, 2021Pfizer/BioNTech
RomaniaGovernment of RomaniaJanuary 8, 2021Pfizer/BioNTech
RussiaGovernment of RussiaJanuary 2, 2021Sputnik V
Saudi ArabiaMinistry of Hajj and UmrahJanuary 6, 2021Pfizer/BioNTech
ScotlandGovernment of the United KingdomJanuary 3, 2021Pfizer/BioNTech
SlovakiaMinistry of HealthJanuary 7, 2021Pfizer/BioNTech
SloveniaNational Institute of Public Health, via SledilnikJanuary 8, 2021Pfizer/BioNTech
SpainMinistry of HealthJanuary 8, 2021Pfizer/BioNTech
SwedenSwedish Medical Products AgencyJanuary 4, 2021Pfizer/BioNTech
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityJanuary 8, 2021Sinopharm
United KingdomGovernment of the United KingdomJanuary 3, 2021Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionJanuary 8, 2021Moderna, Pfizer/BioNTech
WalesGovernment of the United KingdomJanuary 3, 2021Pfizer/BioNTech

Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with on our work on COVID-19, and the many other topics we cover you can sign up to our newsletter.